Schalkwijk and colleagues were the first to report that transgenic rats overexpressing human Glo1 were less susceptible to T1DM-induced cardiac oxidative damage, inflammation, and fibrosis [14]. The gene discussed is GLO1; the disease is type 1 diabetes mellitus.